Century Capital Management’s West Pharmaceutical WST Stock Holding History

Century Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,381	Closed	-$848K	–	206
2016 Q3	$848K	Sell	11,381 -13,667	-55%	-$1.08M	0.1%	197
2016 Q2	$1.9M	Sell	25,048 -8,509	-25%	-$619K	0.21%	162
2016 Q1	$2.33M	Buy	33,557 +7,791	+30%	+$469K	0.26%	160
2015 Q4	$1.55M	Sell	25,766 -80,777	-76%	-$4.86M	0.09%	188
2015 Q3	$5.77M	Buy	+106,543	New	+$6.21M	0.33%	92
2014 Q2	–	Sell	-60,426	Closed	-$2.66M	–	159
2014 Q1	$2.66M	Sell	60,426 -158,724	-72%	-$7.47M	0.12%	140
2013 Q4	$10.8M	Buy	219,150 +27,728	+14%	+$1.3M	0.43%	84
2013 Q3	$7.88M	Sell	191,422 -77,806	-29%	-$2.97M	0.33%	97
2013 Q2	$9.46M	Buy	+269,228	New	+$8.86M	0.37%	101

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Century Capital Management's WST Position: Q4 2016 in Review

Century Capital Management sold out of West Pharmaceutical (WST) in Q4 2016, closing a stake of 11,381 shares — an estimated $848K sold.

Century Capital Management first reported a position in WST in Q2 2013 and held it in 9 quarters. The position peaked at $10.8M in Q4 2013. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

Century Capital Management reported no remaining West Pharmaceutical position as of Q4 2016 after selling out during the quarter.
Century Capital Management sold 11,381 West Pharmaceutical shares in Q4 2016, an estimated $848K.
Century Capital Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 9 quarters.
Century Capital Management's West Pharmaceutical position peaked at $10.8M in Q4 2013.
288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on Century Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.